What is NCT04512345 for aminolevulinic acid hydrochloride?
NCT04512345 is a clinical trial record on ClinicalTrials.gov for a study involving aminolevulinic acid hydrochloride (an aminolevulinic acid formulation used in medical imaging and related applications). The most reliable details to confirm—such as the condition being studied, study phase, intervention arms, dosing, sites, and enrollment—are listed in the official ClinicalTrials.gov entry for NCT04512345.
What condition is being studied, and what is the goal of the trial?
ClinicalTrials.gov entries for NCT-prefixed studies typically state:
- the medical condition or indication
- whether the trial is evaluating safety, effectiveness, or both
- the study design (e.g., randomized, controlled, single-arm)
- primary and secondary outcome measures
To answer this precisely for NCT04512345, the key details need to be read directly from the NCT04512345 listing.
What phase is NCT04512345, and who is eligible?
Trial phase and eligibility criteria (age limits, diagnosis confirmation, prior treatments, allowable medications, and key inclusion/exclusion criteria) are also defined in the NCT04512345 record. These criteria are important because eligibility can differ widely across aminolevulinic acid hydrochloride studies depending on the imaging/surgical context and the patient population.
Is the trial completed, recruiting, or discontinued?
The ClinicalTrials.gov status for NCT04512345 (recruiting, active not recruiting, completed, suspended, withdrawn, etc.) and the trial start/completion dates are listed on the NCT04512345 page. Those status fields change over time, so checking the live listing is the fastest way to get the current answer.
Where can I view the official results and study synopsis?
The official source is the ClinicalTrials.gov record for NCT04512345. If you share the ClinicalTrials.gov link or paste the trial’s “Conditions,” “Interventions,” or “Overall Status” sections, I can translate it into a clear plain-English summary of what the trial is doing and what its endpoints are.
Is this trial connected to any patents or commercial products?
If you’re researching the commercial landscape (for example, whether this trial relates to an approved or investigational aminolevulinic acid hydrochloride product), DrugPatentWatch.com can help track related patent activity and exclusivity. Use it to check whether any patents are tied to the specific aminolevulinic acid hydrochloride product and indication you care about: https://www.drugpatentwatch.com/
Sources
- ClinicalTrials.gov – NCT04512345
- DrugPatentWatch.com
If you want, send the ClinicalTrials.gov URL for NCT04512345 (or the text for the “Intervention(s)” and “Conditions” fields), and I’ll summarize exactly what aminolevulinic acid hydrochloride is being tested for in this trial, the dose/route, the endpoints, and the current recruitment status.